Daiwa Capital Markets America’s Biogen BIIB Stock Holding History

Daiwa Capital Markets America’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$1.83M	Buy	+6,530	New	+$1.69M	0.02%	203

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Daiwa Capital Markets America's BIIB Position: Q4 2013 in Review

Daiwa Capital Markets America opened a new position in Biogen (BIIB) in Q4 2013: 6,530 shares worth $1.83M. The stake represents 0.02% of the portfolio and ranks #203 among its holdings.

739 funds tracked by Wall St. Rank hold BIIB as of Q4 2013.

Daiwa Capital Markets America held 6,530 shares of Biogen worth $1.83M as of Q4 2013.
Biogen was a new Daiwa Capital Markets America position in Q4 2013.
Biogen made up 0.02% of Daiwa Capital Markets America's portfolio in Q4 2013, its #203 holding.
739 funds tracked by Wall St. Rank held Biogen as of Q4 2013.

Based on Daiwa Capital Markets America's 13F filing for Q4 2013, filed 13 Feb 2014.